Preference values associated with stage III colon cancer and adjuvant chemotherapy

被引：0
|
作者：
Jennie H. Best
Louis P. Garrison
William Hollingworth
Scott D. Ramsey
David L. Veenstra
机构：
[1] University of Washington,
来源：
Quality of Life Research | 2010年 / 19卷
关键词：
Preferences; Utilities; Time trade-off; Colon cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：391 / 400
页数：9
相关论文
共 50 条
  • [21] The role of adjuvant chemotherapy in stage II and III mucinous colon cancer
    Fields, Adam C.
    Lu, Pamela
    Goldberg, Joel
    Irani, Jennifer
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1190 - 1200
  • [22] Utilisation of adjuvant chemotherapy for people with stage III colon cancer in NSW
    You, Hui
    Morrell, Stephen
    Lin, Enmoore
    Tervonen, Hanna
    Zhao, George
    Currow, David
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 57 - 57
  • [23] Adjuvant Chemotherapy for Stage III Colon Cancer: Does Timing Matter?
    Czaykowski, Piotr M.
    Gill, Sharlene
    Kennecke, Hagen F.
    Gordon, Vallerie L.
    Turner, Donna
    DISEASES OF THE COLON & RECTUM, 2011, 54 (09) : 1082 - 1089
  • [24] A statewide evaluation of adjuvant chemotherapy for stage III colon cancer.
    Petrelli, N. J.
    Grubbs, S. S.
    Spellman, J. E.
    English, C. L.
    Shevock, A.
    Nunley, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer
    Ginesi, Meridith C.
    Bliggenstorfer, Jonathan T.
    Kwesiga, Daphine M.
    Xu, Samantha H.
    Jodeh, Diana
    Eva Selfridge, J.
    Stein, Sharon L.
    Steinhagen, Emily F.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (09) : 5511 - 5518
  • [26] ADJUVANT CHEMOTHERAPY IN STAGE III COLON CANCER: A REGIONAL CANCER CARE CENTRE EXPERIENCE
    Pokharel, Khageshwor
    Lee, Andrew
    Haigh, Kate
    Sharma, Amit
    Sorour, Natacha
    Grewal, Guranjan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 179 - 180
  • [27] Effect of Postoperative Complications on Adjuvant Chemotherapy Use for Stage III Colon Cancer
    Merkow, Ryan P.
    Bentrem, David J.
    Mulcahy, Mary F.
    Chung, Jeanette W.
    Abbott, Daniel E.
    Kmiecik, Thomas E.
    Stewart, Andrew K.
    Winchester, David P.
    Ko, Clifford Y.
    Bilimoria, Karl Y.
    ANNALS OF SURGERY, 2013, 258 (06) : 847 - 853
  • [28] Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer
    Hershman, Dawn
    Hall, Michael J.
    Wang, Xiaoyan
    Jacobson, Judith S.
    McBride, Russell
    Grann, Victor R.
    Neugut, Alfred I.
    CANCER, 2006, 107 (11) : 2581 - 2588
  • [29] Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
    Khalil, Lana
    Gao, Xingyu
    Switchenko, Jeffrey M.
    Alese, Olatunji B.
    Akce, Mehmet
    Wu, Christina
    Diab, Maria
    El-Rayes, Bassel F.
    Shaib, Walid L.
    ONCOLOGIST, 2022, 27 (09): : 740 - 750
  • [30] Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
    Karim, Safiya
    Booth, Christopher M.
    Brennan, Kelly
    Peng, Yingwei
    Siemens, D. Robert
    Krzyzanowska, Monika K.
    Mackillop, William J.
    CANCER MEDICINE, 2019, 8 (12): : 5590 - 5599
12345